On Tuesday, AnaptysBio Inc (NASDAQ: ANAB) opened higher 6.50% from the last session, before settling in for the closing price of $15.85. Price fluctuations for ANAB have ranged from $12.51 to $41.31 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 201.20% over the last five years. Company’s average yearly earnings per share was noted -0.07% at the time writing. With a float of $25.91 million, this company’s outstanding shares have now reached $30.43 million.
The firm has a total of 117 workers. Let’s measure their productivity. In terms of profitability, gross margin is 95.8%, operating margin of -257.84%, and the pretax margin is -289.74%.
AnaptysBio Inc (ANAB) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of AnaptysBio Inc is 14.86%, while institutional ownership is 103.50%. The most recent insider transaction that took place on Dec 30 ’24, was worth 842,060. In this transaction Director of this company bought 65,184 shares at a rate of $12.92, taking the stock ownership to the 7,860,180 shares. Before that another transaction happened on Dec 31 ’24, when Company’s Director bought 13,268 for $12.93, making the entire transaction worth $171,513. This insider now owns 7,873,448 shares in total.
AnaptysBio Inc (ANAB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.07% per share during the next fiscal year.
AnaptysBio Inc (NASDAQ: ANAB) Trading Performance Indicators
Check out the current performance indicators for AnaptysBio Inc (ANAB). In the past quarter, the stock posted a quick ratio of 10.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.07, a number that is poised to hit -1.62 in the next quarter and is forecasted to reach -5.36 in one year’s time.
Technical Analysis of AnaptysBio Inc (ANAB)
Analysing the last 5-days average volume posted by the [AnaptysBio Inc, ANAB], we can find that recorded value of 0.74 million was better than the volume posted last year of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 88.19%. Additionally, its Average True Range was 1.31.
During the past 100 days, AnaptysBio Inc’s (ANAB) raw stochastic average was set at 15.50%, which indicates a significant decrease from 94.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.51% in the past 14 days, which was lower than the 103.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.40, while its 200-day Moving Average is $26.60. Now, the first resistance to watch is $17.44. This is followed by the second major resistance level at $18.00. The third major resistance level sits at $18.85. If the price goes on to break the first support level at $16.02, it is likely to go to the next support level at $15.17. Should the price break the second support level, the third support level stands at $14.61.
AnaptysBio Inc (NASDAQ: ANAB) Key Stats
There are currently 30,429K shares outstanding in the company with a market cap of 513.64 million. Presently, the company’s annual sales total 17,160 K according to its annual income of -163,620 K. Last quarter, the company’s sales amounted to 30,020 K and its income totaled -32,850 K.
